Spero Therapeutics
We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant ("MDR”) bacterial infections with high unmet need. Our pipeline consists of three mid to late-stage clinical assets. Tebipenem HBr is in Phase 3 development, with the potential to be the first broad-spectrum oral carbapenem to treat complicated urinary tract infections ("cUTIs”) including acute pyelonephritis, caused by certain microorganisms, in adult patients. SPR206 is a Phase 2 ready IV-administered antibiotic being developed as an innovative option to treat MDR Gram-negative bacterial infections in the hospital setting. SPR720, the development of which was recently suspended, is a Phase 2 investigational oral agent for the first-line treatment of nontuberculous mycobacterial ("NTM”) pulmonary disease, a rare disease. As previously disclosed, following the SPR720 program suspension, we are evaluating other potential paths forward as the remaining data are collected and analyzed.
7-day free trial · no credit card
Verified contacts
44
available on Kipplo
LinkedIn employees
48
11 to 50 range
Open roles
—
no listings
Distinct roles
31
indexed titles
Tech stack
5
tools in use
Monthly traffic
731
organic / mo
Sign up free to see all 44 verified contacts at Spero Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
44 contacts with verified email or phone · masked until revealed.
- JC
John C.
Associate Director, Quality Assurance · Information Technology
EmailPhone - JP
John Pottage
Non Executive Director · General Business & Management
EmailPhone - NB
Nivedita Bhatt
Executive Director · General Business & Management
EmailPhone - AJ
Akash Jain
Vice President, Alliance Management and Business Development · General Business & Management
EmailPhone - DK
David K. Hong
Vice President, Clinical Development · Research & Development
EmailPhone - IC
Ian Critchley
Vice President, Head of Clinical Microbiology · Other
EmailPhone - AF
Angela Flynn
Office Manager Executive Assistant · Operations
EmailPhone - CW
Caroline Wass
Senior Clinical Research Associate · Science
EmailPhone - ST
Sharon Therriault
Qa Consultant · Information Technology
EmailPhone
Showing 9 of 44 verified contacts
Top roles at Spero Therapeutics
31 distinct titles indexed · top 10 shown.
- 2()
- 2board member
- 2qa consultant
- 1,,
- 1associate director, fp & a
- 1associate director, quality assurance
- 1chief operating officer, spero therapeutics
- 1executive director
- 1executive director, head of clinical pharmacology, dmpk and drug analysis
- 1icon plc
- +21more titles
Sign up to unlock all 44 contacts at Spero Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 44 verified contacts at Spero Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.